Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and Metformin Combination Therapy in Insulin Resistant PCOS
NCT07307677Recruiting
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of melatonin in polycystic ovary syndrome (PCOS) (2 arms). Primary endpoint: Homeostatic Model Assessment of Insulin Resistance at 12 weeks. Started Mar 2025; status: recruiting.
02
Drugs
melatonin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07307677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07307677.